Keywords: مهارکننده های آلدواز ردوکتاز; Cannabis sativa L. chemotypes; Standardized extracts; Non-psychotropic phytocannabinoids; Aldose reductase inhibitory activity; Molecular docking study; ALR2; aldose reductase; ARIs; aldose reductase inhibitors; â9-THC; â9-tetrahydrocannabinol; CBD; c
مقالات ISI مهارکننده های آلدواز ردوکتاز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکننده های آلدواز ردوکتاز; Rhodanine-3-acetic acids; Aldose reductase inhibitors; Molecular modeling;
Keywords: مهارکننده های آلدواز ردوکتاز; Aldose reductase inhibitors; Antioxidant activity; Quinoxalinones; Phenolic hydroxyl;
Keywords: مهارکننده های آلدواز ردوکتاز; ALR2; aldose reductase; ALR1; aldehyde reductase; ARIs; aldose reductase inhibitors; AKR1B1; aldo-keto reductase family1 member1; AKR1B10; aldo-keto reductase family1 member10; Glc; glucose; Ep; epalrestat; Aldose reductase inhibition; Diabetic compli
Keywords: مهارکننده های آلدواز ردوکتاز; Aldose reductase inhibitors; 1-Hydroxypyrazole; Trifluoroacetylation; Sorbitol accumulation; Differential inhibitors; ALR2; aldose reductase; ALR1; aldehyde reductase; AP-1; activator protein 1; ARIs; aldose reductase inhibitors; DHN; 1,4-dihydroxynonene;
Keywords: مهارکننده های آلدواز ردوکتاز; AR; aldose reductase; ARIs; aldose reductase inhibitors; HNE; trans-4-hydroxy-2,3-nonenal; ARDIs; aldose reductase differential inhibitors; 2-ME; 2-mercaptoethanol; DTT; d,l-dithiothreitol; hAR; human placental recombinant aldose reductase; bAR; bovine le
Keywords: مهارکننده های آلدواز ردوکتاز; AGEs; advanced glycation end-products; ALR1; aldehyde reductase; ALR2; aldose reductase; ARI; aldose reductase inhibitor; BEI; binding efficiency index; DHN; 1,4-dihydroxynonene; GSH; glutathione; HNE; 4-hydroxynonenal; LE; ligand efficiency; LELP; ligand
Keywords: مهارکننده های آلدواز ردوکتاز; Diabetic complications; Organic nitrates; Luteolin; Aldose reductase inhibitors;
Keywords: مهارکننده های آلدواز ردوکتاز; MKFARFANKSESEV-UHFFFAOYSA-N; VHBFFQKBGNRLFZ-UHFFFAOYSA-N; MFVUTOCLDIJSST-GDNBJRDFSA-N; LDSAGOKBOKCGGG-UITAMQMPSA-N; OQODMGVZUIJSIJ-WJDWOHSUSA-N; KIZXRDIROMPMKU-UHFFFAOYSA-N; CZLWAOVKLXEDIA-LSCVHKIXSA-N; PLAIWVZOTHHNSF-UHFFFAOYSA-N; BAVVGXZGQABAAS-GORDUTHD
Pterin-7-carboxamides as a new class of aldose reductase inhibitors
Keywords: مهارکننده های آلدواز ردوکتاز; Aldose reductase inhibitors; Pterin-7-carboxamide; Docking study; Quantitative structure-activity relationship; CGDYFAVFPXPHPZ-UHFFFAOYSA-M;
Anti-osmotic and antioxidant activities of gigantol from Dendrobium aurantiacum var. denneanum against cataractogenesis in galactosemic rats
Keywords: مهارکننده های آلدواز ردوکتاز; DC; diabetic cataracts; AR; aldose reductase; NO; nitric oxide; iNOS; inducible nitric oxide synthase; ARI; aldose reductase inhibitors; PBS; phosphate buffer saline; FBS; fetal bovine serum; NIH; National Institute of Health; MD; molecular docking; PDB;
Structure–activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors
Keywords: مهارکننده های آلدواز ردوکتاز; Quinoxalinone derivatives; Aldose reductase inhibitors; Structure–activity relationshipsALR2, aldose reductase; ALR1, aldehyde reductase; ARIs, aldose reductase inhibitors; AKR, aldo-keto reductase; NADPH, β-nicotinamide adenine dinucleotide phosphate red
Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs)
Keywords: مهارکننده های آلدواز ردوکتاز; Baylis–Hillman reaction; Rhodanine compounds; Epalrestat analogues; Crystal structure; Molecular docking; Aldose reductase inhibitors
Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation
Keywords: مهارکننده های آلدواز ردوکتاز; diabetes; lens; cataracts; in vitro lens culture; aldose reductase inhibitors; sorbitol dehydrogenase inhibitors; iso-osmotic culture; growth factors; bFGF; TGF-β; cell signaling; P-42/44 MAPK; P-SAPK/JNK; P-Akt
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors
Keywords: مهارکننده های آلدواز ردوکتاز; AGEs; advanced glycation-end products; ALR2; aldose reductase; ARIs; aldose reductase inhibitors; 2,4-TZDs; 2,4-thiazolidinediones; Aldose reductase; Enzyme inhibition; Diabetes complications; 4-Thiazolidinones;
High glucose-induced DNA-binding activities of nuclear factor of activated T cells 5 and carbohydrate response element binding protein to the myo-inositol oxygenase gene are inhibited by sorbinil in peripheral blood mononuclear cells from patients with ty
Keywords: مهارکننده های آلدواز ردوکتاز; Myo-inositol; Myo-inositol oxygenase; Type 1 diabetes mellitus; Diabetic nephropathy; Aldose reductase; Aldose reductase inhibitors
Identification of new non-carboxylic acid containing inhibitors of aldose reductase
Keywords: مهارکننده های آلدواز ردوکتاز; Aldose reductase inhibitors; 2,4-Thiazolidinediones; In vitro inhibition; Diabetes complications
Thiol-disulfide exchanges modulate aldo–keto reductase family 1 member B10 activity and sensitivity to inhibitors
Keywords: مهارکننده های آلدواز ردوکتاز; Aldo–keto reductase family 1 member B10; Aldose reductase inhibitors; Reactive oxygen species; thiol/disulfide exchanges; Cysteine; GlutathioneAKR1B10, aldo–keto reductase family 1 B10; AR, aldose reductase; ARI, aldose reductase inhibitor; BME, beta-merc
A combinatorial access to 1,5-benzodiazepine derivatives and their evaluation for aldose reductase inhibition
Keywords: مهارکننده های آلدواز ردوکتاز; Aldose reductase inhibitors; Aryldiazepinothiophenones; Benzodiazepines; o-Phenylenediamines; Mercaptopropionic acid; Multicomponent reaction; Thiazolo[3,4-a][1,3]benzimidazoles;
Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus
Keywords: مهارکننده های آلدواز ردوکتاز; Artemisia dracunculus; Asteraceae; Russian tarragon; Aldose reductase; Aldose reductase inhibitors; Davidigenin; 6-Demethoxycapillarisin; Dihydrochalcones; 2â²,4â²-Dihydroxy-4-methoxydihydrochalcone; 4,5-Di-O-caffeoylquinic acid;
Quantitative structure–activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors
Keywords: مهارکننده های آلدواز ردوکتاز; Aldose reductase inhibitors; 2,4-Thiazolidinediones; Diabetes mellitus; Quantitative structure–activity relationship; Hansch analysis; Fujita-Ban analysis
Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes
Keywords: مهارکننده های آلدواز ردوکتاز; AGE inhibitors; AGE breakers; Aminoguanidine; OPB 9195; LR compounds; Pyridoxamine; Benfotiamine; ALT 711; sRAGE; Metformin; ACE inhibitors; Angiotensin II receptor antagonists; Aldose reductase inhibitors; Diclophenac; Salicylates; Tenilsetam; Flavonoids
The influence of sulindac on diabetic cardiomyopathy: A non-invasive evaluation by Doppler echocardiography in streptozotocin-induced diabetic rats
Keywords: مهارکننده های آلدواز ردوکتاز; Left ventricular dysfunction; Aldose reductase inhibitors; Myocardial fructose; Doppler echocardiography;